Results of Different Location of Ahmed Glaucoma Valve Implantation in Refractory Glaucoma, Superior Versus Inferior

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00628173

Enrollment

106

Registered

2008-03-04

Start date

2005-01-31

Completion date

2007-12-31

Last updated

2008-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

Purpose:To compare the efficacy and safety of Ahmed Glaucoma Valve (AGV) implantation in the superior versus inferior quadrants. Methods: In a non-randomized clinical trial and over a period of two years, consecutive patients with refractory glaucoma underwent AGV implantation in the superior or inferior quadrants. Main outcome measures included best corrected visual acuity (BCVA), intraocular pressure (IOP), number of glaucoma medications, complications and success rate (defined as at least 30% IOP reduction below preoperative values and 5\<IOP\<22 mmHg with or without glaucoma medications). Other criteria for failure included implant removal, additional glaucoma surgery, phthisis bulbi or loss of light perception.

Interventions

PROCEDUREAGV implantation

Study design

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with refractory glaucoma who need AGV implantation

Exclusion criteria

* Eyes with less than 3 months follow-up * Severe conjunctival adhesions and scarring for the site of surgery * Presence of thin sclera and staphyloma for the site of surgery * The presence or anticipated need for silicone oil for superior implantation * Active neovascular glaucoma for inferior implantation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026